ESC 365 - The SGLT2 inhibitor ertugliflozin causes a switch of cardiac substrate utilization leading to reduced cardiac mTOR-signaling, unfolded protein response and apoptosis.

ESC Premium Access

The SGLT2 inhibitor ertugliflozin causes a switch of cardiac substrate utilization leading to reduced cardiac mTOR-signaling, unfolded protein response and apoptosis.

Session: Congress committee e-posters choice in basic science

Topic: Cardiac Hypertrophy

Speaker: Mrs J. Moellmann (Aachen, DE)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Mrs Julia Moellmann

RWTH University Hospital Aachen, Aachen (Germany)

0 follower

19 more presentations in this session

Pharmacological blockade of histone methyltransferase SETD7 restores angiogenic response in experimental diabetes

Speaker: Mr S. Mohammed (Zurich, CH)

Activated myofibroblasts promote cardiac hypertrophy and systolic dysfunction independently of cardiac fibrosis in experimental autoimmune myocarditis

Speaker: Ms K. Tkacz (Cracow, PL)

New insights into the development of radiation-induced cardiac damage using a mouse model

Speaker: Doctor S. Margraf (Essen, DE)

The m6A methyltransferase METTL3 promotes hypoxic pulmonary arterial hypertension via targeting PTEN

Speaker: Doctor Y. Qin (Nanjing, CN)

Senescent endothelial cells exacerbate pulmonary hypertension through notch-mediated juxtacrine interaction with pulmonary artery smooth muscle cells

Speaker: Doctor R. Ramadhiani (Kobe, JP)

Access the full session

Congress committee e-posters choice in basic science

Speakers: Mrs J. Moellmann, Mr S. Mohammed, Ms K. Tkacz, Doctor S. Margraf, Doctor Y. Qin...

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources